Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates

Bibliographic Details
Main Authors:	Rozemeijer, Kirsten, Penning, Corine, Siebers, Albert G., Naber, Steffie K., Matthijsse, Suzette M., van Ballegooijen, Marjolein, van Kemenade, Folkert J., de Kok, Inge M. C. M.
Format:	Online
Language:	English
Published:	Springer International Publishing 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703623/

id	pubmed-4703623
recordtype	oai_dc
spelling	pubmed-47036232016-01-12 Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates Rozemeijer, Kirsten Penning, Corine Siebers, Albert G. Naber, Steffie K. Matthijsse, Suzette M. van Ballegooijen, Marjolein van Kemenade, Folkert J. de Kok, Inge M. C. M. Original Paper Springer International Publishing 2015-10-12 2016 /pmc/articles/PMC4703623/ /pubmed/26458884 http://dx.doi.org/10.1007/s10552-015-0678-1 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Rozemeijer, Kirsten Penning, Corine Siebers, Albert G. Naber, Steffie K. Matthijsse, Suzette M. van Ballegooijen, Marjolein van Kemenade, Folkert J. de Kok, Inge M. C. M.
spellingShingle	Rozemeijer, Kirsten Penning, Corine Siebers, Albert G. Naber, Steffie K. Matthijsse, Suzette M. van Ballegooijen, Marjolein van Kemenade, Folkert J. de Kok, Inge M. C. M. Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
author_facet	Rozemeijer, Kirsten Penning, Corine Siebers, Albert G. Naber, Steffie K. Matthijsse, Suzette M. van Ballegooijen, Marjolein van Kemenade, Folkert J. de Kok, Inge M. C. M.
author_sort	Rozemeijer, Kirsten
title	Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
title_short	Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
title_full	Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
title_fullStr	Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
title_full_unstemmed	Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
title_sort	comparing surepath, thinprep, and conventional cytology as primary test method: surepath is associated with increased cin ii+ detection rates
description
publisher	Springer International Publishing
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703623/
_version_	1613520715723571200

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates

Similar Items